Artiva Biotherapeutics, Inc. (ARTV)
(Delayed Data from NSDQ)
$2.76 USD
+0.12 (4.55%)
Updated Aug 8, 2025 03:59 PM ET
After-Market: $2.76 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Artiva Biotherapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ARTV 2.76 +0.12(4.55%)
Will ARTV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ARTV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARTV
AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy
ARTV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ARTV
Artiva Biotherapeutics GAAP EPS of -$0.87 misses by $0.06
Artiva Biotherapeutics files $300M mixed securities shelf
12 Health Care Stocks Moving In Wednesday's After-Market Session
Artiva Biotherapeutics Approves Equity Plan Amendment
Promising Advancements and Financial Strength Position Artiva Biotherapeutics for Significant Upside